Awareness of genomic testing among patients with breast cancer in Europe
This study highlights insufficient awareness of, and access to, genomic testing in breast cancer. Healthcare professionals need to improve communication with patients regarding genomic testing and involve them in shared decision-making. Likewise, patient associations have a role in providing clear information to patients.
Authors
- Richard Simcock (ORCID: https://orcid.org/0000-0002-9828-4114)
- Concepción Biurrún
- Fátima Cardoso (ORCID: https://orcid.org/0000-0002-6692-2249)
- Csaba László Dégi (ORCID: https://orcid.org/0000-0002-6695-403X)
- Isabel T. Rubio (ORCID: https://orcid.org/0000-0003-0035-0679)
- Rosanna D’Antona
- Antonella Cardone (ORCID: https://orcid.org/0000-0003-3685-1512)
- Johanna Wassermann (ORCID: https://orcid.org/0000-0001-9376-5966)
- Dany Bell
- Francesco Cognetti
- Michael Patrick Lux
- Ana Ramirez Piris
Institutions
- Champalimaud Foundation (PT)
- Macmillan Cancer Support (GB)
- European CanCer Organisation (BE)
- Babeș-Bolyai University (RO)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Exact Sciences (United States) (US)
- Pitié-Salpêtrière Hospital (FR)
- Federación Española de Enfermedades Raras (ES)
- St. Josef Krankenhaus (DE)
- St. Vincenz-Krankenhaus Limburg (DE)
- Clinica Universidad de Navarra (ES)
- Europa Donna (IT)
- Tumori Foundation (US)
- University Hospitals Sussex NHS Foundation Trust (GB)
Publication Details
- Journal
- The Breast
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1016/j.breast.2025.104436
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00